← Evidence map

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2011

Cost-effectiveness evaluation of sunitinib as first-line targeted therapy for metastatic renal cell carcinoma in Spain.

E Calvo Aller et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2011
2012
2013
2014
2015
2016
2017
2018
2019
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 22126730